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Introduction
The formation of the vertebrate inner ear has been postulated
to comprise several stages (Groves and Bronner-Fraser, 2000;
Baker and Bronner-Fraser, 2001; Rinkwitz et al., 2001;
Noramly and Grainger, 2002). Initially, a signal from the
endomesoderm underlying the presumptive otic field initiates
the induction of the otic placode. This process appears to be
complemented by a signal originating from hindbrain neural
tissue next to the developing placode to complete formation of
the otic vesicle. Subsequently, the otic vesicle undergoes a
series of morphogenetic processes, leading to the formation of
distinct subcompartments, including the cochlea, the different
parts of the vestibular system and the endolymphatic sac.
Simultaneously, cellular differentiation leads to the generation
of specialised cell types, including cochleovestibular neurons
and sensory hair cells that permit correct functioning of the
mature sensory organ.
Owing to their gene expression patterns and various
experimental manipulations, several members of the fibroblast
growth factor (FGF) gene family, including FGF2, FGF3,
FGF8, FGF10 and FGF19 have been implicated in different
stages of inner ear formation (Baker and Bronner-Fraser, 2001;
Rinkwitz et al., 2001; Noramly and Grainger, 2002). Among
these, FGF3 in particular has been the earliest candidate
postulated to play a role during early inner ear development.
Initially, it was proposed on the basis of its expression pattern
in the developing hindbrain next to the forming inner ear
placode and vesicle in mice, thus consistent with a role in inner
ear induction (Wilkinson et al., 1988). Furthermore, this early
hindbrain expression pattern is fundamentally conserved
between different vertebrate species including avians
(Mahmood et al., 1995), amphibians (Lombardo et al., 1998a)
and fish (Phillips et al., 2001). This idea gained further
support by experiments in which antibodies and antisense
oligonucleotides, presumably directed against FGF3, blocked
otic vesicle formation in chicken explants (Represa et al.,
1991), although later studies have questioned the conclusions
that were drawn from these experiments (Mahmood et al.,
1995). Further doubt for a role in otic vesicle formation was
derived from the generation of Fgf3 mutant mice, where a
Members of the fibroblast growth factor (FGF) gene family
control formation of the body plan and organogenesis in
vertebrates. FGF3 is expressed in the developing hindbrain
and has been shown to be involved in inner ear
development of different vertebrate species, including
zebrafish, Xenopus, chick and mouse. In the mouse,
insertion of a neomycin resistance gene into the Fgf3
gene via homologous recombination results in severe
developmental defects during differentiation of the otic
vesicle. We have addressed the precise roles of FGF3
and other FGF family members during formation of the
murine inner ear using both loss- and gain-of-function
experiments. We generated a new mutant allele lacking the
entire FGF3-coding region but surprisingly found no
evidence for severe defects either during inner ear
development or in the mature sensory organ, suggesting the
functional involvement of other FGF family members
during its formation. Ectopic expression of FGF10 in the
developing hindbrain of transgenic mice leads to the
formation of ectopic vesicles, expressing some otic marker
genes and thus indicating a role for FGF10 during otic
vesicle formation. Expression analysis of FGF10 during
mouse embryogenesis reveals a highly dynamic pattern of
expression in the developing hindbrain, partially
overlapping with FGF3 expression and coinciding with
formation of the inner ear. However, FGF10 mutant mice
have been reported to display only mild defects during
inner ear differentiation. We thus created double mutant
mice for FGF3 and FGF10, which form severely reduced
otic vesicles, suggesting redundant roles of these FGFs,
acting in combination as neural signals for otic vesicle
formation. 
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neomycin resistance (neor) gene was inserted into the coding
region of this gene via homologous recombination in order to
prevent its expression (Mansour et al., 1993). The analysis of
Fgf3 homozygous mutant mice showed that formation of the
otic vesicle was unaffected, arguing against an early role of
FGF3 during inner ear development. However, defects
affecting the morphogenesis and differentiation of the inner ear
were described, such as a loss of the endolymphatic duct
leading to hydrops of the inner ear, a lack of the posterior
semicircular canal and cochlear sensory neurons, and
behaviors characteristic of inner ear defects. Importantly, only
50% of homozygous mutants were recovered after birth, and
only very few of these animals survived to adulthood.
Moreover, the inner ear phenotype described had reduced
penetrance and expressivity. This could be explained by either
a non-uniform genetic background, the existence of parallel
signaling pathways, leaky expression of the mutant allele, or
any combination of the above. Therefore, the consequences of
a loss of FGF3 function for mouse inner ear development may
not have been fully explored. Indeed, a role for FGF3 during
early inner ear development has gained further support
following its overexpression in chicken embryos, which leads
to the formation of ectopic vesicles expressing otic marker
genes (Vendrell et al., 2000). In the same species, FGF3
expression is also induced by another FGF family member,
FGF19, which together with WNT8C and possibly FGF3 itself,
act as synergistic signals to induce otic development (Ladher
et al., 2000). Next to FGF3, FGF2 and FGF8 have also been
shown to induce ectopic otic structures and/or expression of
genes marking otic identity (Lombardo and Slack, 1998b;
Adamska et al., 2001; Léger and Brand, 2002). Several recent
studies have reported the requirement for both FGF3 and FGF8
function for proper formation of the otic placode and vesicle
in zebrafish, demonstrating the synergistic role of a
combination of different FGF family members acting in a
redundant fashion during this process (Phillips et al., 2001;
Léger and Brand, 2002; Maroon et al., 2002; Liu et al., 2003).
In mice, FGF3 has been suggested to share redundant functions
with FGF10 during tooth morphogenesis (Kettunen et al.,
2000). As the expression of FGF3 and FGF10 also partially
overlap during otic morphogenesis, and they have been
suggested to play roles in forming parallel signaling pathways
(Pirvola et al., 2000), experiments examining functional
relationships between these and other FGF ligands are required
to dissect the complexity of FGF inputs into otic vesicle
formation.
In the present study we address the potential role of FGF3
and other FGF family members, including FGF2, FGF8 and
FGF10 to act as neural signals during murine inner ear
formation. We also generate a new mutant allele for Fgf3 and
find that, unexpectedly, mice that lack the Fgf3-coding region
show no apparent inner ear defects. Ectopic expression of
different FGFs to anterior regions of the developing hindbrain
reveals that FGF10 acts as a potent inducer of ectopic vesicles
with otic character, thereby indicating its capacity to function
as a neural signal during inner ear formation. A role in normal
otic vesicle formation is also supported by its endogenous
expression in the hindbrain next to the developing inner ear
placode and vesicle. Finally, by the analysis of double mutant
mice, we confirm that FGF3 and FGF10 act as redundant
signals during otic vesicle formation. A similar analysis of
double mutant mice for FGF3 and FGF10 has been reported
recently (Wright and Mansour, 2003). 
Materials and methods
Generation of transgenic mice
A genomic fragment containing the FGF3-coding region and a 3 ¢
located 3.2 kb genomic fragment (Peters et al., 1989) were used for
construction of the targeting vector (see Fig. 1A). After
electroporation of ES cells (line E14.1), DNA from G418-resistant
clones was digested with EcoRI and analysed by Southern blot using
a 5¢ external probe (see Fig. 1B). Two clones showing homologous
recombination were injected into blastocysts to generate chimeric
mice. Heterozygous Fgf3cDNAneo/+ mice were mated with deleter-cre
mice (Holzenberger et al., 2000) to remove the Fgf3 cDNA and the
neomycin cassette. Cre-mediated excision was confirmed by Southern
blot and PCR (see Fig. 1B,C). The primer pairs used for the analysis
of the wild-type, targeted and knock-out allele had the following
sequences: wild-type (5 ¢ primer, ATGGGCCTGATCTGGCTTCT-
GCT; 3 ¢ primer, TCCACCGCAGTAATCTCCAGGATGC), cDNAneo
(5¢ primer, ACGACGGGCGTTCCTTGCGCAGCTGTG; 3 ¢ primer,
CCTGGTACTATGGTGCTA), knockout (5 ¢ primer, CATCTCC-
ACCTCTCTCCAG; 3 ¢ primer, CCTGGTACTAT GGTGCTA).
Mice were bred into a mixed 129 · C57/Bl6 background.
Genotyping of adult mice and embryonic offspring revealed the
presence of genotypes at the expected Mendelian ratios. FGF10
knockout mice were genotyped by PCR according to Sekine et al.
(Sekine et al., 1999). After crossing of double heterozygous mice for
FGF3 and FGF10, all combinations of the expected genotypes were
recovered at the expected Mendelian ratios at E9 and E10. However,
no Fgf3–/–/Fgf10–/– mutant embryos were recovered at E11 or E12.
For the generation of transgenic mice expressing FGFs in the
hindbrain a plasmid containing the EphA4 r3/r5 enhancer and a lacZ
reporter gene was used (see Fig. 3A). Murine FGF cDNAs were
amplified by PCR and cloned into the EheI site of the vector.
Transgenic mice were generated and identified by PCR or b -
galactosidase staining, as described previously (Theil et al., 1998).
Ectopic expression of FGFs was verified by RNA in situ hybridisation.
Levels of transgene expression were estimated by RNA in situ
hybridization and b -galactosidase staining. Maximal levels of
transgene expression were found to be similar between embryos
expressing different transgenes.
Histology and RNA in situ hybridization analysis
Embryos were isolated and fixed in 4% paraformaldehyde (PFA) at
4°C between 1 and 3 days and dehydrated through a graded ethanol
series. Embedding was performed using the Kulzer Histotechnique
using Technovit 7100 (Heraeus). Microtome sections (6 m m) were
stained with Toluidine Blue O and mounted on slides with Eukitt
(Sigma). For the preparation of adult inner ears, mice were perfused
with 4% PFA and isolated inner ears were decalcified using
trichloroacetic acid. After a postfixation in 4% PFA inner ears were
processed as described above.
RNA whole-mount in situ hybridization was essentially performed
as described by Conlon and Rossant (Conlon and Rossant, 1992)
using digoxigenin- and fluorescein-labelled riboprobes, which were
detected by using alkaline phosphatase-coupled antibodies. For
double detection, NBT/BCIP (purple) staining was always carried out
first, and the antibody was stripped in 0.1 M glycine-HCl (pH 2.2).
The embryos were then incubated with the other antibody and stained
with INT/BCIP (red). For histological examination, embryos were
postfixed in 4% PFA, embedded in gelatin and sectioned at 30 m m on
a vibratome or embedded in Tissue-Tek (Sakura) and sectioned at 10
m m on a cryostat. For whole-mount RNA in situ hybridization the
following probes were used: Dlx5 (Acampora et al., 1999; Depew et
al., 1999), Sox9 (Ng et al., 1997), Lmx1 (Failli et al., 2002), Pax2
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(Rinkwitz-Brandt et al., 1996), kreisler/Mafb (Giudicelli et al., 2003),
lunatic fringe (Morsli et al., 1998) and full-length cDNA for Fgf3
(kindly provided by Clive Dickson). Fgf10 expression analysis was
performed using a probe corresponding to nucleotides 12-547 (kindly
provided by Rosanna Dono) and a full-length cDNA (Invitrogen). As
negative controls to confirm specificity and fidelity of Fgf10
expression, Fgf10–/– mutant embryos were also used.
Results
Generation of mice lacking the entire Fgf3-coding
region
Previous analyses of the role of FGF3 during mouse inner ear
development have been based on Fgf3neo/neo mutant mice in
which the neor gene had been inserted into exon 1b of the Fgf3-
coding region by homologous recombination (Mansour et al.,
1993). Mice homozygous for this mutation showed defects in
tail formation and differentiation of the inner ear. However, the
analysis of these mice has been complicated by the fact that
fewer than 50% of the expected homozygous mutants were
recovered postnatally, and that the observed inner ear
phenotype showed variation in both penetrance and
expressivity. The latter results may be explained by leaky
expression of the mutant Fgf3 allele as such expression could
not entirely be excluded (Mansour et al., 1993). Therefore, to
define further the in vivo function of FGF3 and to avoid any
potential interference caused by remnants of its coding region
and/or selectable marker genes and/or heterologous promoters
we decided to generate a new mutant Fgf3 allele devoid of all
Fgf3-coding sequences. The sequences contained in exons 1b,
2 and 3 of the Fgf3 gene were replaced by a cDNA encoding
Fgf3 and a neor gene flanked by loxP sites via homologous
recombination (Fig. 1A). Subsequently, the cDNA and the neor
gene were removed by Cre-mediated deletion between the
external loxP sites present in the targeted locus to create
heterozygous Fgf3+/– animals (Fig. 1A; see Materials and
methods). Fidelity of the targeting event in embryonic stem
cells and subsequent Cre-mediated excision was demonstrated
by Southern blots and PCR (Fig. 1B,C; see and Materials and
methods). By crossing heterozygous Fgf3+/– mice we produced
homozygous Fgf3–/– mutant embryos that lack Fgf3 expression
as assayed through whole-mount RNA in situ hybridisation
(Fig. 1D).
FGF3 mutant mice are viable and show tail defects,
but normal inner ears
In contrast to Fgf3neo/neo mutants (Mansour et al., 1993),
Fgf3–/– mice lacking the entire coding region for Fgf3 were
found be viable and fertile and showed no abnormal behavior.
The most striking phenotype of Fgf3–/– mutants was their
shortened, thickened and curved tail (Fig. 2A). This phenotype
was first observed at day 11 of embryonic development (E11)
and has also been described in Fgf3neo/neo mice (Mansour et
al., 1993). To analyse in more detail any inner ear phenotypes
in Fgf3–/– mice, we performed a histological analysis of
developing ears from these mutants from the otic vesicle stage
until adulthood, focusing especially on those structures that
had been described as defective in Fgf3neo/neo mutant mice. At
E10.75 otic vesicles of Fgf3–/– mutants appeared slightly
smaller compared with age-matched wild-type littermates (Fig.
2B,C). However, all of the inner ears of Fgf3–/– mutant animals
examined (n=60) were otherwise found to have an apparently
Fig. 1. Deletion of the Fgf3-
coding region in mice.
(A) The genomic locus with
the exons and coding
regions of the Fgf3 gene
indicated. The coding
region was replaced by a
FGF3 cDNA and a neor
gene flanked by loxP sites
by homologous
recombination. The
introduced sequences were
removed by Cre-mediated
excision between the
external loxP sites.
(B) Southern blot analysis
was carried out using the
probes indicated in A to
detect the correct targeting
event in ES cells and
subsequent deletion of the
introduced sequences.
(C) PCR analysis using
primer pairs indicated by
pink arrows in A
demonstrating the presence
and absence of specific
products amplified from the
targeted locus and after
generation of the knock out allele. (D) Whole-mount RNA hybridisation analysis of Fgf3 expression in the hindbrain of an E8.5 Fgf3–/– mutant
embryo and a wild-type littermate. Scale bar: 100 m m.
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normal morphology, including presence of the endolymphatic
duct, the posterior semicircular canal and cochlear ganglia
(Fig. 2B-E). Adult homozygous mutants showed a normal
Preyer’s reflex and revealed no obvious structural
abnormalities of the cochlea or the vestibular system (Fig. 2F,G
and data not shown). Therefore, we found no evidences that
deletion of the Fgf3-coding region has consequences on
viability or on function of the inner ear. 
Ectopic expression of FGF3 and FGF10 leads to
formation of ectopic vesicles with otic
characteristics
The lack of an inner ear phenotype in Fgf3–/– mutants
suggested the involvement of other FGF gene family members
during early inner ear development. Considerable evidence
exists demonstrating that the hindbrain is a source for FGFs,
which act as neural signals during formation of the otic placode
and vesicle (Represa et al., 1991; Philipps et al., 2001; Léger
and Brand, 2002; Maroon et al., 2002; Liu et al., 2003). We
were thus interested to examine the potential involvement of
FGF2, FGF3, FGF8 and FGF10 during this process, as all these
ligands have been implicated in formation of the otic vesicle
in different vertebrates (Represa et al., 1991; Lombardo et al.,
1998a; Lombardo et al., 1998b; Adamska et al., 2001; Ohuchi
et al., 2000; Vendrell et al., 2000; Léger and Brand, 2002). In
order to test the capacity of these factors to act as a hindbrain-
derived neural signal for otic development in mammals, we
used a misexpression approach by ectopically overexpressing
FGFs to anterior regions of the developing murine hindbrain.
The vertebrate inner ear forms adjacent to a region
encompassing the posterior of rhombomere (r) 4 through r6 of
the developing hindbrain. An enhancer of the Epha4 gene has
previously been used to successfully direct ectopic expression
of genes to r3 and r5 (Theil et al., 1998). The timing and spatial
domain of expression driven by this enhancer coincides with
formation of the otic placode and vesicle, and thus offers a
useful tool to test the capacity of different FGF genes to
function as hindbrain-derived neural signals for formation of
the murine inner ear in an embryologically appropriate
location. FGF misexpression constructs also included a b -
globin minimal promoter and an internal ribosomal entry site
with a lacZ reporter gene, and these constructs were used to
generate embryos for transient analysis and for the generation
of stable transgenic lines (Fig. 3A). Transgenic embryos were
extensively analysed between E9.5 and E10.5, a time when otic
vesicle formation is normally complete. The most striking
phenotype was obtained through ectopic expression of FGF10
(three independent lines). In 85% of the embryos analysed
(n=67) we observed the formation of small ectopic vesicular
structures which formed next to r3, r4 and r5 (Fig. 3B).
Analysis of sections revealed that these structures had a
morphology resembling small rudimentary otic vesicles (Fig.
3C). The otic character of these vesicles was confirmed by the
expression of the Dlx5, Lmx1 and Sox9 genes (Fig. 3D,E; data
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Fig. 2. Tail and inner ear phenotype of Fgf3–/– mutants. (A) Fgf3–/–
adult mutants show a shortened, thickened and kinked tail.
(B,C) Sections through the otic vesicle of a wild-type and a Fgf3–/–
mutant littermate at E10.75. The endolymphatic duct is indicated by
an asterisk. Note the reduced size of the otic vesicle in the mutant
embryo compared with the wild-type control animal.
(D,E) Transverse sections through the inner ear at E13.5. The
cochleovestibular ganglion (cvg), endolymphatic duct (ed) and
posterior semicircular canal are indicated (pc). (F,G) Sections
through the cochlea of wild-type and Fgf3–/– adult mutant littermates.
The cochlear ganglion is indicated by arrows. Scale bars: in C, 200
m m for B,C,F,G; in D, 200 m m for D,E.
Fig. 3. Ectopic expression of FGFs and formation of ectopic otic
vesicles. (A) Construct for the generation of transgenic mice. An
Epha4 r3/r5 enhancer in combination with a b -globin minimal
promoter is used to drive expression of FGFs and an IRES-lacZ
reporter gene in the hindbrain. (B) Formation of an ectopic vesicle
(arrow) anterior to the otic vesicle (OV) in an FGF10 transgenic
embryo. (C) Section through the hindbrain of an FGF10 transgenic
embryo stained for lacZ. An ectopic vesicle (arrow) has formed next
to rhombomere (r) 4. (D,E) Expression of Dlx5 and Lmx1 in ectopic
vesicles (arrows) of FGF10 transgenic mice. Scale bars: in C, 80 m m
for C and 200 m m for B,D; in E, 200 m m for E. 
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not shown), which are expressed in the inner ear
placode and vesicle (Ng et al., 1997; Giraldez, 1998;
Acampora et al., 1999; Depew et al., 1999; Failli et
al., 2002). However, the ectopic vesicles failed to
express the otic markers Pax2 (Rinkwitz-Brandt et
al., 1996) and lunatic fringe (Lfng) (Morsli et al.,
1998), showing that they do not have the capacity to
undergo the complete early developmental program
required for otic vesicle formation (data not shown).
This observation was also confirmed by a lack of
further morphological differentiation beyond the otic
vesicle stage (data not shown). In contrast to the
misexpression experiments using FGF10, we
obtained only one FGF3 transgenic line, which
produced some ectopic structures in very few
embryos from breeding of this line (three out of 63
embryos). Upon analysis of additional independent
transient transgenic embryos, we found only one
embryo (1 out of 15) that showed ectopic vesicles
comparable with those produced in FGF10
transgenic mice (data not shown). Two independent
lines ectopically expressing FGF2 were produced,
but after breeding we failed to identify any embryos
that showed formation of ectopic vesicular
structures. Finally, for FGF8 misexpression
constructs we failed to produce transgenic lines or
transgenic embryos. Whether this was due to
pleiotropic effects of the misexpression construct
leading to reduced embryonic viability was not
determined. In conclusion, these studies
demonstrated that FGF10 in particular (with FGF3 to
a lesser extent) shows a strong capacity to act as a
potent hindbrain-derived neural signal that directs
formation of ectopic vesicles with an otic character
in misexpression experiments. 
Expression of FGF3 and FGF10 during inner
ear formation
Before and during otic placode formation, Fgf3 is
detected in the developing neuroectoderm in a broad
domain that extends from the midbrain-hindbrain
boundary down to r6, with the highest expression
levels present in r4, r5 and r6 next to the developing
otic placode (Fig. 4A) (Mahmood et al., 1996;
McKay et al., 1996). Subsequently, during formation
of the otic pit and vesicle, Fgf3 transcripts are
concentrated in r5 and r6 (Fig. 4B,C) (Mahmood et
al., 1996; McKay et al., 1996). As FGF10 showed a
strong and reproducible capacity to induce ectopic
otic vesicles after overexpression in the developing hindbrain,
we were interested to analyse its endogenous expression
pattern during formation of the otic placode and vesicle.
Between the 0 somite (s) to 4 s stage, Fgf10 was expressed in
the anterior and ventral mesenchyme (Fig. 4D-F). From the 5
s stage onwards, we detected a very dynamic expression in the
developing hindbrain next to the area where the otic placode
and vesicle develops (Fig. 4G-K). To facilitate the detailed
localisation of Fgf10 during early inner ear development in
the developing hindbrain, we performed double in situ
hybridisation of Fgf10 with a probe for the Mafb gene, which
is expressed at the level of r5 and r6 during formation of the
hindbrain (Giudicelli et al., 2003), next to where the otic
placode and vesicle are formed. Before formation of the otic
placode at the 5 s and 7 s stage Fgf10 was expressed in a
domain largely posterior to the anteriormost extent, but
overlapping with posterior Mafb expression (Fig. 4G,H). After
formation of the otic placode at the 10 s and 11 s stage, this
domain extended further posteriorly down the neural tube to
the level of the fifth somite, and anteriorly maintained its
overlapping expression with Mafb in r6 (Fig. 4I). During this
developmental timepoint, an additional domain of Fgf10
expression was detected in the anterior hindbrain. At the 13 s
stage expression of this anterior domain and the posterior
Fig. 4. Expression of Fgf3 and Fgf10 during inner ear formation.
(A-C) Expression of Fgf3 was detected at the stages indicated by whole-mount
in situ hybridization. The position of the prospective rhombomeres and
rhombomeres are indicated. The arrow in B indicates the level of the transversal
section shown in C, where expression in the hindbrain and otic placode can be
observed. (D-N) Expression of Fgf10 was detected by whole-mount RNA in
situ hybridisation at the stages of development indicated. (D-F) Expression of
Fgf10 is observed in the anterior mesenchyme (m). The arrow in D indicates the
level of the transversal section shown in E. A transverse section at this level in a
four-somite stage embryo shows that Fgf10 expression is localized to ventral
anterior mesenchyme (F). (G-N) Expression of Fgf10 in the hindbrain. To
facilitate the localisation of Fgf10 expression relative to the position of
rhombomeres 5 and 6, a probe for the Mafb gene was used in G-K.
(L-N) Transverse sections at the levels indicated by arrows in H,I,K,
respectively, show expression of Fgf10 restricted to the ventral part of the
hindbrain. The broken line in I indicates the position the otic placode. In K and
N, Fgf10 expression is also detected in the anterior part of the otic cup. Scale
bars: in A, 200 m m for A; in B, 200 m m for B; in D, 50 m m for D; in G, 200 m m
for G; in H, 200 m m for H; in I, 200 m m for I; in J, 200 m m for J; in K, 200 m m
for K.
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neural tube domain were both being downregulated but Fgf10
expression was still maintained in r6 and furthermore, now also
extended into r5 (Fig. 4J). Some two somites later (15 s) Fgf10
expression was detected in r5 and the anterior part of the
invaginating otic cup (Fig. 4K). Analysis of sections at these
stages showed that Fgf10 expression was restricted to the
neural tissue of the ventral hindbrain (Fig. 4L-N and data not
shown). Therefore, Fgf10 expression in the developing
hindbrain coincides spatially and temporally with the
formation of the murine otic placode and/or vesicle in the
neighboring ectoderm, and also coincides with some of the
endogenous areas of Fgf3 hindbrain expression.
Otic vesicle formation is severely affected in double
mutant mice for FGF3 and FGF10
The expression of FGF3 and FGF10 in the developing
hindbrain during formation of the otic placode and vesicle
suggested their potential involvement in functioning as neural
signals during this process. However, as shown in the present
study, FGF3 mutant mice carrying a deletion of the coding
region of the gene show an apparently normal formation of the
inner ear (Fig. 2) or in the second mutant allele Fgf3neo/neo
display defects that affect only the differentiation of the otic
vesicle (Mansour et al., 1993). Likewise, FGF10 mutant mice
form otic vesicles, although their size appears reduced and later
differentiation of the inner ear is affected (Ohuchi et al., 2000;
Pauley et al., 2003). To explore the possibility that FGF3 and
FGF10 may act as redundant factors during early inner ear
development, we created mice that were doubly mutant for
these genes. No Fgf3–/–/Fgf10–/– mutant embryos were
recovered later than E10 and we thus concentrated our analysis
on stages between E8 and E10. All Fgf3–/–/Fgf10–/– mutant
embryos examined showed a severe loss of otic tissue (n=26;
Fig. 5). At E8 Fgf3–/–/Fgf10–/– embryos showed a severe
reduction or absence of otic marker genes including Dlx5 and
Pax2 (Fig. 5A-D). At E9 and E10, Fgf3–/–/Fgf10–/– mutants had
formed reduced sized otic vesicles (Fig. 5E-P). These vesicles
were found in a more ventral position compared with controls
and showed a complete lack of the cochleovestibular ganglion
(Fig. 5E,F). The inner ear phenotype showed variable
expressivity between mutant embryos and also between the
two vesicles of the same embryo. In the most affected embryos,
the tiny vesicles formed also showed a dramatic reduction or
absence of otic marker genes, including Pax2, Dlx5 and Sox9
(Fig. 5I-N and data not shown). However, in less affected
embryos, these genes, and also the otic marker Lfng, could be
detected in their normal domains of expression (Fig. 5G,H,O,P
and data not shown). Therefore, although formation of the otic
placode and vesicle is severely disturbed in Fgf3–/–/Fgf10–/–
mutants, expression of otic genes and thus initial
morphogenesis of the inner ear is observed in a subset of
embryos. 
Discussion
Inner ear phenotypes of FGF3, FGF10 and FGF
receptor 2 mouse mutants
FGF3 has been proposed to act as the hindbrain-derived
inducer of the vertebrate inner ear (Wilkinson et al., 1988;
Represa et al., 1991). However, in the present study, we have
not found any evidence that mice with a complete deletion of
the Fgf3 gene show any of the severe inner ear defects
previously described in Fgf3 mutant mice (Mansour et al.,
1993). How can the lack of an inner ear phenotype in Fgf3–/–
Development 130 (25) Research article
Fig. 5. Defects in inner ear formation in Fgf3
and Fgf10 double mutant mice. (A-D) Sections
at the level of the otic placode at E8 (eight
somites) and the invaginating placode (E8.75)
which have been hybridized with the indicated
probes. Note the absence of Dlx5 staining in B.
At E8.75, the otic placode in the mutant embryo
has only initiated its invagination and shows very
weak Pax2 expression (D), whereas strong
expression is detected in the otic cup formed in
the wild-type embryo (C). (E,F) Toluidin Blue
stained sections through the otic vesicle of a
wild-type and a Fgf3–/–/Fgf10–/– mutant
littermate at E10.75. Note the absence of the
cochlear ganglion in the mutant (indicated by an
arrow in the wild-type animal) and a more
ventralized position of the vesicle relative to the
border of the neural tube (marked by asterisks).
(G-P) Expression of the indicated otic marker
genes by whole-mount RNA in situ hybridisation
in wild-type embryos (G,I,K) and
Fgf3–/–/Fgf10–/– mutant littermates at E9.5
(H,J,L,O,P). (M,N) Sections corresponding to
the embryos shown in K,L. The punctated circle
in J,L,N indicates the circumference of the
residual otic tissue formed in the mutants. Note
the complete absence of Dlx5 staining in the
vesicle of the mutant animal in L,N. Scale bars:
in A, 40 m m for A-D; in I, 100 m m for E-P.
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mutants be explained? One major reason appears to be
functionally redundant functions of FGF3 with FGF10. FGF3
and FGF10 have been shown to be co-expressed in the
developing inner ear in several structures (Pirvola et al., 2000)
(this study) and both factors are able to bind with high affinity
to the IIIb isoform of FGF receptor 2 (FGFR2-IIIb) (Ornitz et
al., 1996; Igarashi et al., 1998). Importantly, in the developing
inner ear FGF10 is more intensely and widely expressed when
compared with FGF3 (Pirvola et al., 2000) (this study).
Specifically, high levels of expression of FGF10 are observed
in the neurogenic region of the inner ear and the developing
endolymphatic duct. Defects in these structures have been
reported in FGFR2-IIIb mutant mice (Pirvola et al., 2000), but
not in FGF10 mutant animals (Ohuchi et al., 2000; Pauley et
al., 2003) thus indicating that FGF3 and FGF10 function
mutually compensate for each other in these areas in Fgf10–/–
and Fgf3–/– mutants, respectively. Indeed, Fgf3 is also
expressed in the neurogenic region (McKay et al., 1996;
Pirvola et al., 2000) (N. Powles and M. Maconochie,
unpublished), and the absence of a cochleovestibular ganglion
in Fgf3–/–/Fgf10–/– mutants further supports functional
redundancy between these factors. However, Fgf3 expression
has not been detected in the endolymphatic duct (McKay et al.,
1996; Pirvola et al., 2000). In this context, it has been
postulated that FGF3 may control formation of the
endolymphatic duct via its expression in the neighbouring
hindbrain (Mansour et al., 1993; McKay et al., 1996).
Remarkably, we also now describe expression of FGF10 in the
hindbrain next to developing inner ear (Fig. 4), which may thus
also influence the morphogenesis of the inner ear via this
source. 
Both FGFR2-IIIb and FGF10 mouse mutants develop
smaller otic vesicles and show defects during further
morphogenesis and differentiation (Ohuchi et al., 2000; Pirvola
et al., 2000; Pauley et al., 2003). However, as the phenotype of
FGFR2-IIIb mutants is more severe than the one observed in
the single FGF10 knockout mice, other FGF ligands are
required to control inner ear development via this receptor
isoform. Additionally, the IIIc isoform of FGFR2 may also be
involved during inner ear formation, as well as the ligands
binding this isoform, because hypomorphs affecting all FGFR2
isoforms (Xu et al., 1998) show an otic vesicle that is even
smaller than the one observed in FGFR2-IIIb mouse mutants
(Pirvola et al., 2000). Finally, the severity of the inner ear
phenotype observed in some of the Fgf3–/–/Fgf10–/– double
mutants may only be explained by the interaction of FGF3 and
FGF10 with additional FGF receptors next to FGFR2. In this
context, it is noteworthy that FGFR1-IIIb has also been shown
to act as a functional receptor for FGF3 (Ornitz et al., 1996)
and FGF10 (Beer et al., 2000).
A key question raised by our results is the explanation
underlying the phenotypic differences observed between the
Fgf3–/– mutants described in this study and more severe
phenotypes noted in Fgf3neo/neo animals (Mansour et al., 1993).
In the latter strain, a postnatal loss of homozygous mutants and
inner ear phenotypes had been reported. Fgf3neo/neo mutants
show defects during formation of the endolymphatic duct and
the cochlearvestibular ganglion that are also observed in
FGFR2-IIIb mutant mice (Mansour et al., 1993; DeMoerlooze
et al., 2000; Pirvola et al., 2000). Therefore, the most likely
reason for the differences observed between Fgf3–/– and
Fgf3neo/neo mice is that in the latter mutants, the compensatory
mechanisms present in Fgf3–/– mutants (see above) are not
active. Thus, variations between the genetic background of
these different Fgf3 mutant strains may well underlie the
observed phenotypic differences. However, we have started to
backcross mice carrying the deletion of Fgf3 onto the Bl6
background but have so far not observed any differences from
the phenotypes described in the present article. Alternatively,
the contrast of this phenotype with that observed in Fgf3neo/neo
mutants may be explained by the presence of the neor gene in
the Fgf3neo/neo locus, which may influence the expression and
function of neighboring genes (Lewandoski, 2001). This may
then lead to the inner ear defects and/or a reduction of viability
of Fgf3neo/neo mutants. To clarify this issue further we are at
present creating mice in which the Fgf3 gene has been replaced
by the neor gene.
Consequences of ectopic expression of FGFs in the
hindbrain on inner ear development
Several studies have suggested an important role for FGFs as
hindbrain-derived signals controlling inner ear induction
(Represa et al., 1991; Phillips et al., 2001; Léger and Brand,
2002; Maroon et al., 2002; Liu et al., 2003). To address the
capacity of different FGFs to direct the formation of the inner
ear, we used a gain-of-function approach by ectopically
expressing FGFs in the anterior hindbrain. This aim was
achieved for FGF2, FGF3 and FGF10 by expressing them
under the control of the Epha4 enhancer that drives expression
in r3 before and during formation of the otic placode and
vesicle. Using this enhancer, we were unable to obtain
transgenic mice that ectopically express FGF8. However,
unlike in zebrafish (Phillips et al., 2001), FGF8 is not expressed
in the hindbrain of mice (Lin et al., 2002) and is therefore
unlikely to influence mouse otic development via this tissue.
Nevertheless, FGF8 may still participate in inner ear
development because it is transiently expressed in the otic
placode of chicks (Adamska et al., 2001) and the preplacodal
ectoderm in mice (Crossley and Martin, 1995). Although we
obtained transgenic mice ectopically expressing FGF2, no
phenotypic changes could be observed. Moreover, so far we
have found no evidence for localized expression of FGF2
within the hindbrain near the otic region (Vendrell et al., 2000)
and in addition, FGF2 mouse mutants show no defects during
inner ear development (Dono et al., 1998). Therefore, unlike
in Xenopus and chick embryos, FGF2 does not appear to
influence otic development in mice. However, it is important
to note that in the latter cases FGF2 was applied via beads
implanted into the mesenchyme of the embryos, which may
explain the different experimental outcomes. By contrast, we
found that ectopic expression of FGF3 and FGF10 in r3 of
transgenic embryos resulted in the formation of ectopic
vesicles with otic character. However, the capacity of FGF10
to direct the development of these vesicles was much stronger
than for FGF3. Possibly, this difference could be explained by
an overlap of ectopic FGF10 expression with endogenous
FGF3 expression in r3 (Mahmood et al., 1995; McKay et al.,
1996), which may result in a more potent combined signal to
induce ectopic vesicles in FGF10 transgenic embryos. Vice
versa, owing to its endogenous expression restricted to the
posterior part of the hindbrain, an overlap between FGF10
expression (Fig. 4) and ectopic FGF3 expression in r3 in FGF3
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transgenic embryos does not occur during otic induction and
thus may lead to a much weaker single signal for the formation
of ectopic vesicles. To further address the potential
cooperativity between FGF3 and FGF10, we have created
double transgenic embryos containing both misexpression
transgenes, but have not obtained an increased frequency of
ectopic vesicle formation compared with single transgenic
embryos (Y.A. and T.S., unpublished). In summary, our results
show that expression of FGF10 (and to a lesser extent FGF3)
in the hindbrain is sufficient to direct the formation of ectopic
vesicles expressing otic markers. Similar results have been
obtained in zebrafish, where ectopic otic vesicles are observed
upon anterior expansion of both FGF3 and FGF8 expression
in the hindbrain (Phillips et al., 2001). As suggested earlier
(Léger and Brand, 2002), these results indicate that hindbrain
tissue by itself may contain signals sufficient to direct the
formation of the early inner ear. 
Control of inner ear formation by FGFs in
vertebrates
Both mesoderm and neural tissue contribute to the formation
of the inner ear placode and vesicle. However, at present there
is a lack of information about which molecular signals are
necessary or sufficient to execute this developmental program.
Our present results demonstrate that both FGF3 and FGF10
are necessary for formation of the otic vesicle in mice.
Interestingly, FGF10 expression is observed in the mesoderm
and hindbrain during embryonic development. At the 0 s stage,
FGF10 was detected in anterior mesenchyme, which may
correspond to an area where the future otic placode will be
formed in the overlying ectoderm. Therefore, mesenchymal
expression of FGF10 has been suggested to act as an inductive
signal for inner ear formation (Wright and Mansour, 2003).
However, shortly after this stage (4 s) and before the otic
placode has formed, mesenchymal FGF10 expression is
observed in a more ventral position (Fig. 4F), which will give
rise to pharyngeal mesoderm (Kelly et al., 2001). Importantly,
FGF3 is not detected in the anterior mesenchyme, but is co-
expressed with FGF10 in r5 and r6 of the developing hindbrain
before and during otic placode induction (see Fig. 4) (McKay
et al., 1996; Mahmood et al., 1996). Additionally, FGF10, and
to a lesser extent FGF3, are sufficient to induce the formation
of ectopic vesicles with otic characteristics, when they are
expressed ectopically in the developing hindbrain (see above).
The co-expression of both genes in the developing murine
hindbrain thus suggest that they may act as redundant neural
signals during inner ear formation. A similar scenario is
apparent in the zebrafish, where FGF3 and FGF8 are co-
expressed in r4 and have been shown to control inner ear
formation in a redundant fashion (Phillips et al., 2001; Maroon
et al., 2002; Léger et al., 2002; Liu et al., 2003). 
Loss of FGF3 and FGF8 expression in the zebrafish leads to
a failure to induce the otic placode or vesicle (Phillips et al.,
2001; Maroon et al., 2002; Léger and Brand, 2002; Liu et al.,
2003). In this context, it was also proposed that FGF3 and
FGF8 are responsible for epithelial organization of placodal
cells to form the otic vesicle (Liu et al., 2003). In addition to
these morphological observations, a reduction or loss of otic
marker gene expression, including members of the Pax, Dlx
and Sox transcription factor gene families was described
(Phillips et al., 2001; Maroon et al., 2002; Léger and Brand,
2002; Liu et al., 2003). Interestingly, a differential dependence
of transcription factors on the expression of FGF3 and FGF8
has been demonstrated (Liu et al., 2003). Specifically,
expression of sox9a and pax2.1 the zebrafish orthologues of
mouse Sox9 and Pax2 are severely affected in zebrafish mutants
for both FGF3 and FGF8 (Phillips et al., 2001; Maroon et al.,
2002; Léger and Brand, 2002; Liu et al., 2003). In contrast to
these zebrafish mutants, we consistently observe the presence
of small otic vesicles in Fgf3–/–/Fgf10–/– mouse mutants,
showing that the capacity to organise an otic epithelium is still
maintained in these mutants. We have examined expression of
Pax2, Dlx5 and Sox9 in these vesicles and found a severe
reduction or absence of expression in the most affected
Fgf3–/–/Fgf10–/– mutants. In a very recent publication, similar
results have been reported for Fgf3neo/neo/Fgf10–/– mutant
embryos (Wright and Mansour, 2003). However, in contrast to
the latter study in less affected vesicles of Fgf3–/–/Fgf10–/–,
normal patterns of otic marker gene expression could be
observed, indicating that proper inner ear morphogenesis had
been initiated. As discussed above, the inner ear phenotypes
observed in Fgf3neo/neo versus Fgf3–/– mutants are also likely
to underlie the subtle differences found between the
phenotypes of Fgf3neo/neo/Fgf10–/– and Fgf3–/–/Fgf10–/–
animals. The inner ear phenotypes of Fgf3–/–/Fgf10–/– mouse
mutants can clearly be considered less severe compared to the
zebrafish mutants lacking FGF3 and FGF8. A further
difference between zebrafish and mouse mutants may be also
present in the hindbrain. Whereas the zebrafish mutants show
a loss of hindbrain markers (Maves et al., 2002; Walshe et al.,
2002), including a complete absence of Mafb expression in r5
and r6, we have observed an unaltered expression of this gene
in the hindbrains of Fgf3–/–/Fgf10–/– mouse mutants (Y.A., V.V.
and T.S., unpublished). This indicates that although the inner
ear defects caused by the absence of FGF genes in zebrafish
and mouse are rather similar, there are different consequences
on the hindbrain development in these species. A less severe
defect in the hindbrain of Fgf3–/–/Fgf10–/– mice may thus
also explain the reduced severity of the otic phenotype.
Alternatively, FGF3 and FGF10 may act in a completely
different mode by directly signaling to and/or within the otic
ectoderm.
Conflicting evidence exists on the inhibition of FGF
signaling during inner ear induction by using an inhibitor for
FGF receptors. Whereas Léger and Brand (Léger and Brand,
2002) reported a complete block of inner ear formation and
otic marker genes, Maroon et al. (Maroon et al., 2002) still
observed the presence of pax8 expression which is considered
as one of the first steps of otic placode induction in vertebrates.
Therefore, the initial steps of inner ear development including
formation of the otic placode may be independent of FGF
signaling. Interestingly, recent results have shown that the
zebrafish forkhead-related transcription factor foxi modulates
FGF signaling required for inner ear formation (Nissen et al.,
2003). Although its expression is independent of FGF
signaling, foxi interacts with FGF3 and FGF8 by maintaining
their expression (Nissen et al., 2003). Furthermore, inner ear
formation may involve additional FGF family members. In
chick, FGF4 is expressed in a region which will give rise to r4-
r6 (Shamim et al., 1999; Shamim and Mason, 1999) and thus
has been suggested as an additional hindbrain-derived signal
because of its early co-expression with FGF3 (Mahmood et al.,
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1995; Maroon et al., 2002). In mice, expression of FGF15, the
orthologue of chicken FGF19, has also been observed in the
hindbrain next to the developing inner ear (McWhirther et al.,
1997). In chicks, FGF3, FGF4 and FGF19 are all expressed in
the mesoderm underlying the prospective otic territory
(Mahmood et al., 1995; Shamim and Mason, 1999; Ladher et
al., 2000). The participation of the endomesoderm in inner ear
induction has also been suggested by the analysis of zebrafish
one-eyed-pinhead mutants (Mendonsa and Riley, 1999;
Phillips et al., 2001). However, in a different study of these
mutants, it was concluded that otic induction can largely
proceed normally in the absence of cephalic endomesoderm
and that signals from the hindbrain are sufficient for inner ear
induction (Léger and Brand, 2002). 
On the basis of the phenotype observed in Fgf3–/–/Fgf10–/–
mutants, we suggest that these FGF signals reinforce and/or
maintain early inner ear induction and then subsequently
participate in patterning of the otic vesicle. The potential
involvement of other FGFs in the endomesoderm and
hindbrain, and any redundant functions shared with FGF3 or
FGF10 will now similarly have to be further addressed during
inner ear induction in mice.
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